Healthcare provider profile · identity verified

Alina Poll

Nurse Practitioner · PLANTATION, FL · NPI 1104425669

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	549	221
Amlodipine Besylate	Amlodipine Besylate	392	162
Metformin Hcl	Metformin Hcl	294	112
Baclofen	Baclofen	290	133
Gabapentin	Gabapentin	242	103
Lisinopril	Lisinopril	210	88
Omeprazole	Omeprazole	200	84
Vitamin D2	Ergocalciferol (Vitamin D2)	198	104
Folic Acid	Folic Acid	150	67
Hydrochlorothiazide	Hydrochlorothiazide	150	63
Glipizide	Glipizide	137	52
Jardiance	Empagliflozin	127	22
Losartan Potassium	Losartan Potassium	126	59
Labetalol Hcl	Labetalol Hcl	118	49
Cyproheptadine Hcl	Cyproheptadine Hcl	113	55
Diclofenac Sodium	Diclofenac Sodium	106	49
Nifedipine Er	Nifedipine	101	42
Tamsulosin Hcl	Tamsulosin Hcl	97	43
Pantoprazole Sodium	Pantoprazole Sodium	88	36
Furosemide	Furosemide	86	37
Latanoprost	Latanoprost	83	37
Trazodone Hcl	Trazodone Hcl	82	34
Alendronate Sodium	Alendronate Sodium	69	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	25
Meloxicam	Meloxicam	61	33
Simvastatin	Simvastatin	61	27
Mirtazapine	Mirtazapine	59	26
Memantine Hcl	Memantine Hcl	57	21
Famotidine	Famotidine	54	29
Fenofibrate	Fenofibrate	54	23
Carvedilol	Carvedilol	52	19
Januvia	Sitagliptin Phosphate	51	suppressed
Metoprolol Succinate	Metoprolol Succinate	51	25
Clopidogrel	Clopidogrel Bisulfate	48	18
Ketoconazole	Ketoconazole	47	25
Ibuprofen	Ibuprofen	45	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	18
Pravastatin Sodium	Pravastatin Sodium	43	17
Metoprolol Tartrate	Metoprolol Tartrate	40	17
Pioglitazone Hcl	Pioglitazone Hcl	39	17
Rosuvastatin Calcium	Rosuvastatin Calcium	39	16
Clonidine Hcl	Clonidine Hcl	36	14
Levothyroxine Sodium	Levothyroxine Sodium	36	14
Tizanidine Hcl	Tizanidine Hcl	36	17
Xarelto	Rivaroxaban	35	suppressed
Diclofenac Potassium	Diclofenac Potassium	34	19
Albuterol Sulfate Hfa	Albuterol Sulfate	33	12
Farxiga	Dapagliflozin Propanediol	32	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	16
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	15
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	30	12
Glimepiride	Glimepiride	28	13
Tradjenta	Linagliptin	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	14
Brimonidine Tartrate	Brimonidine Tartrate	26	suppressed
Eliquis	Apixaban	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	12
Donepezil Hcl	Donepezil Hcl	25	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	25	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	23
Escitalopram Oxalate	Escitalopram Oxalate	22	11
Glipizide Er	Glipizide	22	suppressed
Finasteride	Finasteride	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Benzonatate	Benzonatate	20	19
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Methylprednisolone	Methylprednisolone	19	17
Spironolactone	Spironolactone	19	suppressed
Azithromycin	Azithromycin	17	12
Timolol Maleate	Timolol Maleate	17	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Lovastatin	Lovastatin	15	suppressed
Lumigan	Bimatoprost	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Tadalafil	Tadalafil	14	suppressed
Atenolol	Atenolol	13	suppressed
Cilostazol	Cilostazol	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Kerendia	Finerenone	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error